The ARP Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with ASD.

This award mechanism is designed to support innovative

credit: Care2

How's Your Community Doing?
Check Out it's
Community Vital Signs

ideas with the potential to yield impactful data and new avenues of investigation.

The FY18 ARP Idea Development Award seeks applications from all areas of basic and preclinical research and strongly encourages applications that address the critical needs of the ASD community in one or more of the following areas:
• Assessment of novel therapeutics using valid preclinical models • Environmental risk factors • Mechanisms of heterogeneous clinical expression of ASD • Mechanisms underlying conditions co-occurring with ASD (e.g., sleep disturbances, gastrointestinal issues, inflammation, aggression, depression, anxiety, attention deficit, seizures) • Factors promoting success in key transitions to independence for individuals living with ASD • Development of healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD across the lifespan and the continuum of care (i.e., primary care, urgent/emergent care, and disaster relief) • Improve diagnosis across the lifespan • Cultural and socioeconomic factors in treatment efficacy, delivery, and access to services